carbamazepine / Generic mfg. |
NCT05419180: Study of Interest of Stiripentol and Carbamazepine in the Treatment of Patients With Pharmacoresistant Focal Epilepsies |
|
|
| Recruiting | 4 | 100 | Europe | Stiripentol | Biocodex | Pharmacoresistant Focal Epilepsies | 09/23 | 01/24 | | |
2018-002633-38: MCDS-Therapy - Repurposing of carbamazepine (CBZ) for the treatment of skeletal dysplasia in children |
|
|
| Not yet recruiting | 1/2 | 40 | Europe | Tegretol 100mg Tablets, Tegretol 200mg Tablets, Tegretol Liquid 100mg/5ml, Tegretol 400mg tablets, [Tegretol 200 mg], [Tegretol 400 mg], [Tegretol 20 mg/mL Sciroppo], [DIBASE 10.000 U.I./ml], Tablet, Oral liquid, Tegretol 100mg Tablets, Tegretol 200mg Tablets, Tegretol Liquid 100mg/5ml, Tegretol 400mg tablets | The Newcastle upon Tyne Hospitals NHS Foundation Trust, ISTITUTO ORTOPEDICO RIZZOLI, European Commission Horizon 2020, Comunità Europea | Metaphyseal chondrodysplasia type Schmid (MCDS), Metaphyseal chondrodysplasia, Schmid type (MCDS), is a very rare inherited disorder characterized by short stature with abnormally short arms and legs (short-limbed dwarfism) and bowed legs (genu varu, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
NCT05418582: Drug-drug Interactions Between DZD9008 and Itraconazole/Carbamazepine |
|
|
| Completed | 1 | 40 | US | DZD9008 and intraconazole, DZD9008 and carbamazepine | Dizal Pharmaceuticals | Healthy Subjects | 06/22 | 12/22 | | |
NCT05594602: Drug-Drug Interaction Study Between EDP-235, Itraconazole, Carbamazepine and Quinidine in Healthy Subjects. |
|
|
| Completed | 1 | 36 | US | EDP-235, Itraconazole, Carbamazepine, Quinidine | Enanta Pharmaceuticals, Inc | COVID-19 | 12/22 | 12/22 | | |
NCT05581823: Study to Evaluate the Effects of Cytochrome P450 (CYP) 3A4 Inducer Carbamazepine on Tavapadon Pharmacokinetics in Healthy Adult Participants |
|
|
| Completed | 1 | 16 | US | Tavapadon, CVL-751, PF-06649751, Carbamazepine | Cerevel Therapeutics, LLC | Parkinson Disease | 01/23 | 02/23 | | |
NCT05552196: A Study of Ponesimod in Healthy Adult Participants |
|
|
| Completed | 1 | 28 | Europe | Ponesimod, JNJ-67896153, ACT-128800, Ponvory, Carbamazepine, Tegretol | Janssen Pharmaceutica N.V., Belgium | Healthy | 03/23 | 03/23 | | |
NCT05824143: Open-label Trial to Evaluate the Effect Carbamazepine on Darigabat Pharmacokinetics in Healthy Adult Participants |
|
|
| Completed | 1 | 13 | US | Darigabat, CVL-865, Carbamazepine | Cerevel Therapeutics, LLC | Healthy Participants | 07/23 | 07/23 | | |
NCT05860933: A Study of the Effects of Itraconazole or Carbamazepine on LY3537982 in Healthy Participants |
|
|
| Completed | 1 | 30 | US | LY3537982, Itraconazole, Carbamazepine | Eli Lilly and Company, Loxo Oncology, Inc. | Healthy | 08/23 | 08/23 | | |
NCT05994807: A Drug-Drug Interaction Study to Assess the Pharmacokinetics of DC-806 When Orally Administered Alone, When Coadministered With Itraconazole, and When Coadministered With Carbamazepine in Healthy Adult Participants |
|
|
| Completed | 1 | 33 | US | DC-806, Itraconazole, Carbamazepine | DICE Therapeutics, Inc. | Healthy Volunteers | 09/23 | 09/23 | | |
PK, NCT06005688: A Study to Understand the Effects of Carbamazepine on How Vepdegestrant is Processed in Healthy Participants |
|
|
| Completed | 1 | 12 | Europe | Vepdegestrant, ARV-471, PF-07850327, Carbamazepine, Tegretol | Pfizer, Arvinas Estrogen Receptor, Inc. | Healthy Participants | 10/23 | 11/23 | | |
NCT05932303: A Study to Assess the Effect of Multiple Doses of Itraconazole, Gemfibrozil, or Carbamazepine on BMS-986278 in Healthy Participants |
|
|
| Completed | 1 | 47 | Canada | BMS-986278, Itraconazole, Gemfibrozil, Carbamazepine | Bristol-Myers Squibb | Healthy Participants | 10/23 | 10/23 | | |
NCT06028464: A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of BI 1810631 in the Blood |
|
|
| Completed | 1 | 16 | Europe | BI 1810631, Carbamazepine | Boehringer Ingelheim | Healthy | 12/23 | 12/23 | | |
NCT05840952: A Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Drug-Drug Interaction Potential of Single and Multiple Doses of ALG-097558 |
|
|
| Recruiting | 1 | 144 | Europe | ALG-097558, Placebo, Midazolam, Itraconazole, Carbamazepine, ALG-097558 in solution formulation, ALG-097558 in tablet formulation | Aligos Therapeutics | COVID-19 | 04/24 | 07/24 | | |
NCT05965219: A Trial to Evaluate the Effects of Itraconazole and Carbamazepine on the Pharmacokinetics of Emraclidine and of Emraclidine on the Pharmacokinetics of Metformin in Healthy Adult Participants |
|
|
| Completed | 1 | 60 | US | Emraclidine, Itraconazole, Sporanox, Carbamazepine, Tegretol-XR, Metformin, Glucophage | Cerevel Therapeutics, LLC | Healthy Volunteers | 11/23 | 11/23 | | |
NCT06173596: A Study to Evaluate Potential Drug Interactions Between ALXN2080 and Itraconazole, Fluconazole & Carbamazepine in Healthy Adults |
|
|
| Completed | 1 | 60 | Europe | ALXN2080, Itraconazole, Fluconazole (AxMP), Carbamazepine (AxMP) | Alexion Pharmaceuticals, Inc. | Healthy | 04/24 | 05/24 | | |
NCT06071442: Potential Drug Interaction Study Between Vemircopan and Rosuvastatin, Metformin, Levonorgestrel/Ethinyl Estradiol-containing Oral Contraceptives, and Carbamazepine |
|
|
| Completed | 1 | 60 | US | Vemircopan, ALXN2050, Rosuvastatin, Metformin, Levonorgestrel / Ethinyl Estradiol, SIMPESSE, Carbamazepine | Alexion Pharmaceuticals, Inc. | Healthy Participants | 04/24 | 04/24 | | |
NCT06345794: A Study to Assess LY4100511 (DC-853) in Healthy Adult Participants |
|
|
| Recruiting | 1 | 50 | US | LY4100511 (DC-853), DC-853, Itraconazole, Fluconazole, Carbamazepine | DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company, Eli Lilly and Company | Healthy | 06/24 | 06/24 | | |
NCT06348888: A Study to Learn About How Itraconazole and Carbamazepine Affect the Level of BAY2927088 in the Blood When These Drugs Are Taken Together by Healthy Participants |
|
|
| Completed | 1 | 30 | US | BAY2927088, Itraconazole, Carbamazepine | Bayer | Advanced Non-small Cell Lung Cancer, EGFR Mutation, HER2 Mutation, Healthy Volunteers | 06/24 | 06/24 | | |
NCT06370728: A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants |
|
|
| Recruiting | 1 | 30 | US | Orforglipron, LY3502970, Carbamazepine | Eli Lilly and Company | Healthy | 07/24 | 07/24 | | |